Identification of Predictive Markers for Testis Cancer in a Population of Men With High Risk
Sponsor: Centre Hospitalier Universitaire de Nice
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Centre Hospitalier Universitaire de Nice
- Diabetic Cardiomyopathies · Phase NA · Dec 2023
- Escherichia Coli Infections · Sep 2023
- Healthy Volunteers · Phase NA · Jul 2023
- Chronic Kidney Disease · Phase NA · Dec 2022
- Premature Birth · Phase NA · Sep 2022
See all terminations from Centre Hospitalier Universitaire de Nice
Other Testicular Cancer trials with similar outcome
This NA trial investigates Testicular Cancer and is currently terminated or withdrawn. Centre Hospitalier Universitaire de Nice leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Jan 2017 — Jun 2018 [monthly]
Terminated NA
First recorded
Sep 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nice
For direct contact, visit the study record on ClinicalTrials.gov .